Boston Business Journal (blog) | Editas Medicine Raises $120 Million to Advance Genome Editing Business Wire (press release) CAMBRIDGE, Mass.--(BUSINESS WIRE)--Editas Medicine, a leading genome editing company, today announced that it has raised $120 million in a highly oversubscribed Series B private financing. The financing assembles a broad syndicate of leading ... Cambridge-based Editas gets $120M investment to advance genome editing Gene Editing Startup Raises $120 Million to Apply CRISPR to Medicine Deerfield Invests $20 million in Editas Medicine |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]23/en/Editas-Medicine-Raises-1